Zoe Dunn’s recent article, “Should pharma abandon social media?” raised some compelling points that called into question pharma’s approach to patient engagement through social media. Can social media provide a demonstrable ROI? Is pharma willing to commit to a long-term relationship, a critical underpinning of social media engagements?